1360 Willow Road Menlo Science & Technology Park, Suite 201,
Menlo Park, California 94025
ForteBio is a wholly-owned subsidiary of Pall Corp. and a division of Pall Life Sciences. ForteBio develops analytical systems that enable real-time analysis of biomolecular interactions (protein quantification and characterization of protein-protein interactions, etc.) in micro-volume sample sizes, providing information on affinity, kinetics, and concentration.
ForteBio was acquired by Pall on December 19, 2011.
Join Mergr to view all 162 acquisitions of life science companies in 2011, including 18 acquisitions by private equity firms, and 144 by strategics.
Join Mergr to view this profile - and discover more life science acquisitions of companies like ForteBio.
No obligation. Cancel anytime.